M. Cejuela

Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma

A. Petit, P. Gargallo, M. Gil-Gil, 2022, Modern Pathology.

Immune Check-Point Inhibitors in Breast Cancer: Current Evidence and Future Directions

S. Pernas, M. Mosteiro, M. Cejuela, 2021, Austin Journal of Surgery.

Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma

A. Petit, P. Gargallo, M. Gil-Gil, 2022, Modern Pathology.

Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer

S. Pernas, M. Cejuela, A. Vethencourt, 2022, Current Oncology Reports.

Metformin and Breast Cancer: Where Are We Now?

B. Martín-Castillo, J. Menéndez, S. Pernas, 2022, International journal of molecular sciences.

Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer

M. Ruíz-Borrego, S. Molina-Pinelo, M. A. Castilla, 2023, International journal of molecular sciences.

Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities

M. Cejuela, M. Dominguez-Cejudo, Ana Gil-Torralvo, 2023, International journal of molecular sciences.